Inflammation of pancreas due to previously wounded pancreas, or chronic damage with persistent pain or mal-absorption is known as Chronic Pancreatitis. The major causes of chronic pancreatitis include- alcohol, autoimmune disorder, intraductal obstruction, idiopathic pancreatitis, tumors, ischemia and calcific stones. This could also be hereditary in some cases. Besides, it is usually observed that the patients with cystic fibrosis are most likely to suffer from chronic pancreatitis. The major symptoms observed in patients are frequent weight loss, severe abdominal pain, diarrhea, vomiting and nausea among others.
There are several methods for the diagnosis of chronic pancreatitis that include trans abdominal ultrasound, pancreatic function test, pancreas exocrine function test, Computerized Tomography (CT) scans, Magnetic Resonance Cholangiopancreatography (MRCP), endoscopic ultrasound, genetic testing and Endoscopic Retrograde Cholangiopancreatography (ERCP). All the major testing and diagnosis methods have been analyzed in the report. Market revenue, estimation and forecast of these tests have also been incorporated along with the major developments and innovations in the field. CT scan and trans-abdominal ultrasound are the most commonly preferred diagnosis tests for chronic pancreatitis.
The report identifies and analyzes the key industry factors affecting the revenue generation in the chronic pancreatitis market. It also includes the major market dynamic factors such as drivers, restraints, challenges and opportunities and their impact on the industry in next 5 years. The report tracks the entire value chain of the chronic pancreatitis market along with the suppliers and distributor analysis. Moreover, the industry attractiveness section in the offers the significance of the competitive rivalry in the market affected by the forces such as power of supplier, power of buyer, threat of new entrant and threat of substitution. The report provides precise and comprehensive insights on the market trends, industry trends and macro & micro factors impacting the market growth.
The report offers in depth analysis of therapies used in treatment of chronic pancreatitis pain. The major therapies include surgery, medication and endoscopy. Medical is most commonly preferred therapy which intends at treating the concurrent symptoms with the help of analgesic drugs. Endoscopy is highly complex therapy with fewer efficacies. However, this therapy is considered more pain free and effective than surgery. This is used to prevail over pancreatic duct obstruction caused by ampullary stenosis, strictures, or stones. Research study says that around 14% of the patients treated by endoscopy were pain free compared to 36% treated by surgery. The report also analyzes the penetration of these therapies across all major geographies.
The market of chronic pancreatitis pain in further segmented with respect to major geographies of North America, Europe, Asia-Pacific and Latin America. Moreover, the countries generating high revenue in these regions have also been analyzed along with exhaustive coverage of developments and innovation in these countries. The report also offers extensive research on the key players in this market and detailed insights on the competitiveness of these players.
Sample Companies Profiled in this Report are:
- APtalis Pharma, Inc
- Sun Biopharma
The key business strategies such as mergers & acquisitions, partnerships, collaborations and contracts adopted by the major players are also identifies and analyzed in the report.